Genertec Universal Medical Group Company Limited (5UM) — Capital Reinvestment Ratio
Genertec Universal Medical Group Company Limited (5UM) has a Capital Reinvestment Ratio of 0.10x as of December 2022, meaning it reinvests 0% of its operating cash flow (€1.69 Billion) in capital expenditures (€170.49 Million). See Genertec Universal Medical Group Company (5UM) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Genertec Universal Medical Group Company Limited Capital Reinvestment Ratio (2022–2025)
This chart tracks Genertec Universal Medical Group Company Limited's Capital Reinvestment Ratio across 4 annual periods. Check Genertec Universal Medical Group Company total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Genertec Universal Medical Group Company Limited (2022–2025)
Year-by-year Capital Reinvestment Ratio for Genertec Universal Medical Group Company Limited from 2022 to 2025. For live market cap and broader valuation context, see 5UM company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | €5.78 Billion | €988.91 Million | ▼ -84.5% |
| 2024 | 1.10x | €1.14 Billion | €1.26 Billion | ▲ +514.0% |
| 2023 | 0.18x | €4.99 Billion | €896.83 Million | ▼ -39.2% |
| 2022 | 0.30x | €2.06 Billion | €608.09 Million | — |